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Previous tudies on the mechanism of enteropathogenic Escherichia co# (EPEC) infection have revealed an increase in the phosphorylation state 
of a number or" proteins in human laryngeal HEp-2 cells. The most prominent was an acidic phosphoprotein(s) of Mr 20-21 kDa. The present study 
reports: (a) a simple method for purification of phosphorylated 20 kDa protein: (b) identification of the 20 kDa phosphoprotein asmyosin light 
chain; and (c) that the phorbol ester. TPA, also increased the phosphorylation f the 20 kDa myosin light chain. In contrast to the effects of EPEC, 
TPA stimulation resulted in the dis~nc'iation of myosin from the cytoskeleton to the cytosol. 
Myosin light chain: Protein phosphorylation: Protein kinase C: Enteropathogenic Esclterichia co~i; Caco-2 cell; HEp-2 cell 
1. INTRODUCTION 
Isolates, taken from cases of  severe infantile diarrhea, 
of non-toxin secreting enteropathogenic E. o# (EPEC) 
[1] have a pronounced effect on the phosphorylation 
levels of proteins in human laryngeal (HEp-2)epithelial 
cells, used as a model for studying the pathogenic mech- 
anism of the disease [2]. We have observed similar 
effects on the levels of phosphorylation with okadaic 
acid (1Manjarrez et al., in preparation). This toxin is the 
causative factor in 'diarrhetic shellfish poisoning' [3]. 
Using Caco-2 cells (derived from human colon), 
Burnham and Fondacaro [4] have shown that both the 
20 and 21 kDa light chains of myosin are phospho- 
rylated after treatment with secretagogues that induce 
increased membrane chloride permeability. We have 
demonstrated an increase in the phosphorylation f the 
20-21 kDa proteins after EPEC infection [2] and now 
present evidence for their identification as myosin light 
chain. 
Non.muscle myosins have been identified in many 
cell types. Most consist of two heavy chains and two 
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pairs of light chains [5]. A 21 dDa light chain, thought 
to be an isoform of the 20 kDa regulatory form has also 
been identified in pancreatic acini and stimulation of 
acinar secretion has been shown to be accompanied by 
an increase in phosphorylation f both these forms to 
roughly equal extents [6]. In non-muscle cells the 20 
kDa myosin light chain (MLC) is phosphorylated by a 
specific calcium-activated/calmodulin-dependent en- 
zyme, MLC kinase [7]. This enzyme activity has been 
identified in enterocyte brush-border preparations [8] 
which are the most extensively non-muscle cell in terms 
ofcytoskeletal structure and the role of MLC phospho- 
rylation in cell function. 
In this paper we describe a simple purification pro- 
cedure for the phosphorylated 20 kDa protein from 
Hep-2 and Caco-2 epithelial cells. These fatter cells are 
of particular importance since they are able to express 
spontaneous differentiation features which are charac- 
teristic of typical brush-border microvilli [9]. Also 
reported is the characterisation a d subsequent iden- 
tification of the 20 kDa phosphoprotein as MLC with 
the use of antibodies. Identification of the EPEC-in-" 
duced phosphoproteins may be of particular im- 
portance in understanding the mechanism of pathoge- 
nicity of EPECC-induced diarrhetic disease. Their 
respective roles and those of the associated kinases and 
phosphatates are important in the function of the intes- 
tinal epithelium with respect to shape, change and secre- 
tion. 
Puldished h.v Elsevier Science Puhh'shcrs B, V. 121 
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2. MATERIALS  AND METHODS 
2.1. Materials 
[~2P]Orthophosphate (carrier free; I mCb'ml) was obtained from 
Amersham International, UK. Purified antibodies which specifically 
bind to residues 6-23 of the phosphorylated tbrm of regulator)' light 
chain of smooth muscle myosin and antimyosin heavy chain (smooth 
muscle) antiserum were kindly supplied by Dr J. Bennett, Department 
of Anatomy and Cell Biology, St Mary's Hospital Medical School and 
Dr A.I. Magee, National Institute for Medical Research, Mill Hill. 
London. respectively. Antimyosin (bovine smooth and skeletal mus- 
cle) antiserum was obtainccl from Sigma. All other reagents were 
analytical grade, from BDH or Sigma. 
2.2. Bacterial strains and culture 
Single colonies of EPEC strain E2348-69 (0127), isolated from a 
case of severe infantile diarrhea [10] and laboratory E. coli strain 
I-IBI01 (included as a negative control) [1] were inoculated into 10 ml 
aliquots of Luria broth and incubated overnight at 37°C without 
agitation to the mid.exponential phase before use. 
2.3. Cell culture and protein phosphorvlation in intact cells 
(HEp-2) cells were grown in Dulbccco's Modified Eagle Medium 
(DMEM) supplemented with 100% (v/v) foetal calf serum (FCS) in 
Nunc cell factories (culture area 6000 cm:. Caco-2 cells were grown 
in 8 em diameter Petri dishes in DMEM/20% (v/v) FCS and were 
allowed to fully differentiate [9]. Cells were maintained at 37°C in a 
humidified atmosphere of air enriched with 5% CO:. 
Prior to phosphorylation experiments, cells were maintained for 20 
h in DMEM containing 0.5% (v/v) FCS to obtain quiescent cells, 
followed by 4 h in phosphate-free DMEM/0.5% (v/v) FCS and 50-100 
/.tCi ofcarrier-free "~"P~ (to label the intracellular ATP pool). HEp-2 and 
Caco-2 cells were infected with a bacterial suspension (10 ~ CFU in 0.3 
ml) for 2 h at 37°C. HEp-2 cells were also stimulated with tetradeca- 
noylphorbol-13-aeetate (TPA: 200 riM) for 2 h. To terminate the 
phosphorylation reaction, cells were rapidly washed with ice-cold 
phosphate-buffered saline, removed from the dish by scraping with a 
rubber policeman and transferred into Eppendorf tubes containing 50 
mM NaF, 1 mM PMSF. The cells were frozen, and complete lysis was 
ensured by sonication on ice for 5-10 s. The cytosolic (supernatant) 
fraction was separated from the membrane (pellet) fraction by cen- 
trifugation for 15 min at 4C in a microcentrifuge. 
2.4. Polyacrvlamide g l electrophoresis m~d immunoblotting 
SDS-PAGE was adapted from Laemrnli [11] using 10 and 12.5% 
gels, stained either with Coomassie brilliant blue or silver adapted 
from Blum et al. [12]. Two-dimenstional gel eleetrophoresis was per- 
formed according to O'Farrell [13]. Western blotting was performed 
according to [14]. 
2.5. Purification of the 20 kDa pllosphoprotein 
The supernatant (2ml) from HEp-2 or Cacu-2 cells (following TPA 
or EPEC treatment) was applied in 0.5 ml aliquots to size-exclusion 
column (TSK G2000 SW; 7.5 mr~ x 30 cm), equilibrated with buffer 
A (25 mM phosphate buffer pH 5.5). containing 10% (v/v) propan-1-ol 
(flow rate 0.5 ml/min). 1 ml fractions were collected and the presence 
of the 20 kDa protein detected as described below. Fractions contain- 
ing the 20 kDa protein were peeled and frozen at -20°C. After 
thawing, the fractions were centrifuged (microfuge, 15 rain) and the 
.supernatant applied to a Menu S cation-exchange column 
(Pharmacia; 5 x 50 mm) equilibrated in buffer A on B Pharmacia 
FPLC system. The column was extensively washed with buffer A and 
bound proteins were elutcd by application of a linear NaCI gradient, 
0-1.0 M over 20 rain at 1 ml/min. Fractions (1.0 ml) containing the 
20 kDa phosphoprotein were pooled, desalted using a Sephadex 
column (Pharmacia PD.10) and concentrated by Centricon 10 micro- 
concentrators (Amicon). 
Following each stage of the purification, the 20 kDa phospho- 
protein was detected by running aliquots on SDS polyacrylamide g ls 
with subsequent autoradiography on Kodak X OMAT S at -70°C. 
To assess recoveries, the 10 kDa phosphoprotein (located by auto- 
radiography of wet unfixed gels) was cut from the gel and radioactivity 
counted using Cerenkov counting. The remainder of the gel lane was 
cut into slices of equivalent size as that containing the 20 kDa protein, 
and counted. Summation of the counts from all slices gave a value for 
total radioactivity from which rccove;-,¢ of the 20 kDa protein was 
calculated. In order to overcome apparent losses through radioactive 
decay, samples from pools before and after each purification stage 
were run on the same polyacrylamide gel.
2.6. Amino acid analysis and protein estimation 
Hydrolysis was carded out at IO0°C for 24 h with 6 M HCI/2 mM 
phenol in the vapour phase under nitrogen. Amino acids were detected 
with an Applied Biosystems 420A derivatiser fitted with an on-line 
130A phenylthiocarbamyl amino acid analyser, using reagents 
supplied by the manufacturer. 
Protein content was estimated by the method according to Lowry 
[15] or by quantitave amino acid analysis. 
2.7. bnmunoprecipitation 
After protein phosphorylation experiments, cells were rapidly 
washed in cold PBS. and were removed from the dish in PBS contain- 
ing 50 mM NaF and 1 mM PMSF. Cells were frozen and complete 
lysis was ensured by sonication on ice for 5- I 0 s. (i) Immunopreeipita. 
tion was achieved, using antibodies to denatured phosphorylated 
myosin regulatory light chains and protein-A-Sepharose beads 
(Pharmaeia), from cell lysates after denaturing in SDS-PAGE sample 
buffer (100°C, 5 min). (ii) To immunoprecipitate native cytosolic 
proteins the supernatant fraction was diluted with 2 vols of cold RIP 
buffer (150 mM NaCI, 1% NP-40, 0.5% Dec ,  50 mM Tris-HCl, pH 
8.0), protease inhibitors were added (0.2 mM leupeptin, 20/,tg/ml 
pepstain A, 0.3 mg/l aprotinin and 10 mM benzamidine) and in- 
cubated with either antimyosin or antimyosin heavy chain serum 
(1 : 10 dilution) on ice for 1 h. To collect he antibody-antigen immu- 
nocomplexes, 30/.d of 1 : 1 suspension of protein-A-sepharose beads 
(Pharmacia) was added and incabated for I h at 4°C with rocking. The 
resulting complexes were collected by brief centrifugation, the pellet 
was washed three times with ice cold RIP buffer and once with 50 mM 
Tris-HCl, pH 6.8. (iii) To immunoprecipitate cytoskeleton associated 
proteins, cell pellets were resuspended in cold lysis buffer ( 1.0% NP-40, 
40 mM sodium pyrophosphate, pH 7.4, 0.4 M NaCI, I0 mM EDTA, 
0.1 M NaF, 1 mM benzamidine). After standing on ice for 30 rain, the 
lysed cells were briefly sonicated and were centrifuged in a bench 
microcentrifuge for 20 rain. The supernatant was incubated with the 
antisera s described in (ii). lmmunoprecipitated proteins were ana- 
lysed by either one or two-dimensional PAGE. 
3. RESULTS 
3.1. Phosphorylation of  the 20-21 kDa protein in HEp-2 
and Caco-2 cells after treatment with TPA or fol- 
lowing #Tfection with EPEC isolates 
I ncubat ion  o f  HEp-2  mono layers  for 2 h w i th  e i ther  
TPA or  EPEC stra in  E2348-69 caused increased  phos-  
phory la t ion  o f  both  20 and  21 kDa prote ins  (F ig.  1). 
T reatment  o f  Caco-2  cells fo r  2 h wi th EPEf  "rain 
E2348-69 a lso resul ted in a s igni f icant  enhancement  o f  
the phosphory la t ion  state o f  these prote ins .  The  phos-  
phory la t ion  pat terns  resu l t ing  f rom EPEC in fec t ion  in 
the two cell lir. es were s imi lar .  
3.2 Purification and amino ac#! analysis o f  the 20 kDa 
phosphoprotein 
The e lu t ion  prot i le  o f  32P-radio label led cytoso l i c  
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Fig. 1. Effect of EPEC and TPA on HEp-2 and Caco-2 cell protein 
phosphorylation. Autoradiograph ofSDS-PAGE analysis of proteins 
phosphorylated after incubation for 2 h of: lane 1, (control) untreated 
HEp-2 cells; lane 2, HEp-2 cells after treatment with EPEC strain 
E2348-69, lane 3, HEp-2 cells after treatment with TPA; lane 4, Caco-2 
cells after treatment with EPEC strain E2348-69. The level of phos- 
phorylation in unstimulated Caco-2 cells was similar to that of un- 
treated HEp-2 cells (data not shown). 
proteins separated on a size-exclusion column from 
TPA-stimulated HEp-2 cells is shown in Fig. 2A. Anal- 
ysis of the fractions by SDS-PAGE and subsequent au- 
toradiography (Fig. 2B) showed that the 20 kDa protein 
eluted with an apparent molecular weight of 45 000. 
Most of the protein in fractions containing the 20 kDa 
phosphoprotein (pooled from multiple TSK G2000 SW 
separations) was observed to precipitate after freezing 
and thawing; 95% of the 20 kDa phosphoprotein 
(estimated from SDS-PAGE and Cerer'.kov counting) 
was recovered in the supernatant of this preparation 
after microfuging, with 80% of the total protein 
(estimated by Lowry determination) contained in the 
pellet. As a final purification, the supernatant was 
loaded on a Mono S cation-exchange column. The 20 
kDa protein eluted from the column as two discrete 
peaks; 65% of the recovered 20 kDa protein did not 
bind to mono S and was contained in the flowthrough, 
with the remainder eluting as a broad peak at approx- 
imately 0.4 M NaCI (Fig. 3). Analysis of the latter peak 
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Fig. 2. (A) Size-exclusion chromatography of HEp-2 cytosolic pro- 
teins, following TPA stimulation, on TSK G2000 SW column, eluted 
with 0.25 mM phosphate buffer, pH 5.5, monitored at 280 nm (A2a0) 
and collected in 0.5 ml fractions. The column was calibrated using 
molecular weight marker proteins (e); bovine serum albumin (67 
kDa), ovalbumin (43 kDa), carbonic anhydrase (30 kDa), myoglobin 
(17.3 kDa) and eytochrome c (12.3 kDa). The elution position of the 
20 and 21 kDa proteins is marked by the horizontal bar. (B) Autora- 
d iograph of SDS-PAGE analysis of successive fractions (14-23) from 
the size-exclusion column. The positions ofmolecular weight proteins; 
phosphorylase b (94 kDa), bovine serum albumin (67 kDa), ovalbu- 
rain (43 kDa), carbonic anhydrase (30 kDa), trypsin inhibitor (20 kDa) 
and lactalbumin (14.4 kDa), are indicated (-) from top to bottom, 




by SDS-PAGE showed a single silver staining band 
with an apparent molecular weight of 20 000 (see Fig. 
4A, lane 4), which was also detected by autoradiog- 
raphy (Fig. 4B, lane 4). This phosphorylated prepara- 
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Fig. 3. Elution of the 20 kDa phosphoprotein by Mono S cation- 
exchange chromatography. Supernatant, resulting from centrifuga- 
tion alter freezing and thawing or size-exclusion chromatography frac- 
tions containing the 20 and 21 kDa phosphoproteins, was loaded on 
to a Mono S column, and bound protein (A.v,o) eluted with a linear 
concentration gradient of NaCI. Two peaks of radioactivity both 
containing the 20 kDa protein were identified and pooled separately: 
one was contained in the flow-through of the column (also containing 
the 21 kDa phosphoprotein), and the second eluted at approximately 
0.4 M NaCI on the gradient. 
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Fig. 4. Polyacrylamide g l electrophoresis of the 20 kDa phosphopro- 
rein at each stage of purification. (A) SDS polyacrylamide g l analysis 
of H Ep-2 cytosolic proteins, lane I (Coomassie stained): lane 2, 20 and 
21 kDa phosphoprotein pool after size-exclusion chromatography 
(Coomassie stained): lane 3. supernatant resulting from freezing/ 
thawing this pool (Coomassie stained); lane 4. peak eluting from 
Mono S cation-exchange colunm containing 20 kDa phosphoprotein 
(silver stain, highlighted by the arrow). Note the staining on lane 4 at 
approximately 60 kDa is artifactual (this may be keratin) and is 
routinely seen on silver stained "blank lanes'. (B) The corresponding 
autoradiograph of the gel lanes shown in A. 
tion was used for amino acid analysis, The 21 kDa 
phosphoprotein co-purified with the 20 kDa protein 
until the Mono S purification step. The 20 kDa protein 
bound and could be eluted from Mono S by a salt 
gradient, whereas the 21 kDa form was not retained by 
the column. A very similar elution pattern at each stage 
of the purification procedure was obtained for phos- 
phorylated 20 and 21 kDa proteins from Caco-2 cells 
after EPEC infection. However, the recovery of the 20 
kDa phosphoprotein was low (20% compared to TPA 
stimulated HEp-2 cells). 
Both the 20 and 21 kDa phosphoproteins were poorly 
stained by Coomassie blue. probably because of their 
unusually acidic pl. They could be detected with the 
carbocyanine dye 'Stains-Air under conditions op- 
timized for phospboproteins (data not shown). Fig. 4 
shows a 12.5% SDS polyacrylamide gel and corre- 
sponding autoradiograph of the 20 kDa protein 
preparation from HEp-2 cells at various stages of pu- 
rification. The recovery of the 20 kDa phosphoprotein 
is shown in Table I. 
Amino acid analysis of the purified 20 kDa phospho- 
protein is shown in Table I1. The values are in good 
agreement with those for an average of two mammalian 
smooth muscle light chains and a human non-sarco- 
meric 20 kDa regulatory light chain, except for Glu/ 
Gin, lle and Phe. From unsuccessful attempts at direct 
protein sequencing, we have concluded that the 20 kDa 
protein is N-terminally blocked. 
3.3. hnmunoprecipitation 
Quiescent cells, labelled with [3-'P]orthophosphate, 
were treated with either TPA or EPEC and immunopre- 
cipitation was performed with three different antibod- 
ies. Following lysis in SDS-PAGE sample buffer, anti- 
bodies against phosphorylated myosin light chain 
showed cross-reactivity with the 20 kDa phospho- 
protein on Western blot analysis of SDS-PAGE (data 
not shown) and by immunoprecipitation with subse- 
quent 2D PAGE analysis (Fig. 5). Following lysis in 
buffer containing protease and phosphatase inhibitors 
but excluding detergents, the cytosolic (supernatant) 
fraction was immunoprecipitated using antibodies 
raised against myosin complex (anti-M) or antibodies 
raised against the myosin heavy chain (anti-MHC); Fig. 
6A shows subsequent SDS-PAGE (Coomassie blue 
staining and autoradiography). Bands corresponding to 
myosin heavy chain (MHC), myosin light chain (MLC) 
and actin (A) were observed only after TPA treatment 
(lane b). Their corresponding autoradiography shows 
that both MHC and MLC were phosphorylated (lane 
b). The co-precipitation f actin was explained by per- 
sistence of actomyosin complexes under the mild lysis 
conditions. After EPEC treatment myosin complex is 
still largely associated with the cytoskeleton and it 
remains in the membrane fraction (pellet). In contrast, 
incubation with anti-MHC antibodies (Fig. 6B) resulted 
in the appearance of bands corresponding to 'L'P-la- 
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belied MHC, unlabelled MLC and actin (lane b and b'). 
However the 3'P-phosphorylated 20-21 kDa did not 
immunopreeipitate with these antibodies (lane b'), 
suggesting that phosphorylated MLC is dissociated 
from the myosin complex when cells are treated with 
TPA. None of these proteins were immunoprecipitated 
if the antiserum was replaced by normal rabbit serum 
(data not shown). Phosphorylated MHC and MLC 
were detected by immunoprecipitation when non-ionic 
detergents were used to lyse the cells and solubilize 
proteins in EPEC-treated cells (data not shown). 
4. DISCUSSION 
Adherence of EPEC strain E2348-69 to HEp-2 and 
differentiated Caco-2 cells induced pronounced phos- 
phorylation of several groups of proteins (Fig. 1). OF 
these the 20-21 kDa phosphoproteins have been shown 
to appear after treatment of HEp-2 cells with a variety 
&agents including protein kinase activators (TPA, epi- 
dermal growth factor, phosphatidic acid, phospholipase 
C) and angiotensin II [2], (and Manjarrez et al., in 
preparation). Based on molecular weight, pl and reac- 
tivity with antibodies, the 20 kDa phosphoproteins have 
now been identified as the phosphorylated forms of 
MLC. In support of this finding, okadaic acid (the in- 
hibitor of protein phosphatases 1 and 2A) which 
produces an increase in the phosphorylation states of 
MLC in non-muscle cells [16], also caused a net increase 
in phosphorylation of the 20-21 kDa proteins in both 
HEp-2 and Caco-2 cells (Manjarrez et al., in prepara- 
tion). Since the anti-M antibodies recognise both MHC 
and MLC, immunoprecipitation of the phosphorylated 
20 kDa MLC from cytosolic extracts of TPA stimulated 
cells does not indicate whether this protein is part of an 
intact myosin complex. This i clarified by using anti- 
IviHC antibodies when both MHC and unphosphory- 
lated MLC were immunoprecipitated butthe phospho- 
rylated 20 kDa protein was not (Fig. 6B, lane b and b'). 
We conclude that phosphorylated 20 kDa MLC .is no 
longer part of intact myosin following TPA stimulation, 
Presumably, TPA causes a net release of myosin and/or 
actomyosin from the cytoskeleton with dissociation of 
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Fig. 5. 2-D PAGE analysis of phosphoproteins from Caco-2 after 
incubation for 2 I1 with EPEC strain E2348-69 and imrnunoprecipita- 
tion with antibodies pecific for the phosphoforrn of the regulatory 
light chain. The only silver stainable protein present tdata not shown) 
was that corresponding to the area blackened on the autoradiograph. 
The position of the 20 kDa protein is shown arrowed together with 
the pl range. The lower Mr radioactive spot is probably due to par- 
tially proteolyzed phosphorylted myosin light chain. 
by protein kinase C. As a consequence, this phospho- 
protein, now identified as a phosphorylated MLC could 
be purified by the method escribed above. 
It has been shown that the regulatory MLC of some 
invertebrate myosins can be selectively dissociated from 
myosin by a combination of 5,5'-dithiobis(2-nitro- 
benzoic acid) (DTNB) and EDTA [7]. The 20 kDa phos- 
phoproteins were immunoprecipitated after EPEC in- 
fection of HEp-2 cells only from solubilised cytoskeletal 
proteins. This would indicate that phosphorylation of
MLC, in this case, does not correlate with release of 
myosin or myosin light chain from the cytoskeleton. 
Therefore, this may indicate that phosphorylation 
Table I 
Purification table of lhe 20 kDa phosphoprotein 
Purification step Pool volume Protein 20 kDa cpm/mg x 10 -3 
(ml) (mg) (cpm x 10 -3 ) 
Cell sonication/centrifugation 2.0 45.0 118.7 2.6 
Size exclusion chromatography 8,0 6.0 94.1 15.7 
Freezing/thawing centrifugation 7.5 0.78 70.6 90.5 
Cation-exhange chromatography 10.0 0.02 24.7 1235.0 
Recovery of the 20 kDa phosphoprotein from HEp-2 monolayers (from 20 × 8 cm diameter Petri 
dishes) after EPEC infection. The recovery was scaled up using Nunc cell factories. 
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Fig. 6. 10% SDS-PAGE gels of immunopreeipitated cytosolic proteins from HEp-2 cells. Plus and minus indicate treatment with and without TPA 
or EPEC, respectively. (A)Cytosolic proteins before (Cyt and Cyt') and after immunoprecipitation with anti-M, and (B) with anti-MHC. A, aetin; 
MHC, myosin heavy chain; MLC, myosin light chain (Cyt, a,b and c, Coomassle stain; Cyt', a',b' and e', autoradiograph). Positions of molecular 
weight markers are indicated (-) and are; myosin heavy chain (205 kDa), phospholipase b (97.4 kDa), bovine serum albumin (68 kDa). ovalbumin 
(43 kDa), carbonic anhydrase (29 kDa) and fl-lactoglobulin (18.4 kDa), from top to bottom, respectively. 
occurs at different sites and is caused by different 
kinases, i.e. protein kinase C or MLC kinase, depending 
on the type of  stimulation. 
Hyperphosphorylation of MHC and MLC have been 
reported to occur in a variety of non-muscle cells in 
response to TPA [18]. It also has been shown that TPA 
induces reversible shape changes and synergic cy- 
toskeletal reorganization in fibroblasts [19]. This 
suggests that MLC has an important function in a 
variety of physiological and pathological events. 
Elevated phospborylation levels could be a consequence 
of protein phosphatase inhibition in addition to or as 
an alternative to the activation of several kinases 
through different ransduction pathways. 
Phosphorylation of the 20-21 kDa proteins in EPEC- 
mediated iarrhea only occurs on infection by strains of 
EPEC that induce localized degeneration of  microvilli 
through cytoskeletal breakdown and membrane ve- 
siculation [2]. It is tempting to speculate, therefore, that 
increased levels of  phosphorylated MLC trigger events 
culminating in these so-called pedestal structures (ac- 
cumulation of actin at he point of  br :. -rial contract) 
[10]. This is consistent with the phospho, ylation effect 
on MLC by angiotensin II, which also causes mor- 
phological changes in brush-border cells reminiscent of  
the lesion-forming effects of  EPEC [20]. 
The nature of  the protein kinases involved in the 
direct phosphorylation f MLC isoforms in response to 
various agonists, is as yet unclear. Non-muscle myosins 
have been shown to contain 5 different sites ofphospho- 
rylation [21] and in vitro are substrates for as many 
kinases [22]. In vivo, they have been shown to be phos- 
phorylated by protein kinase C as wei.r as myosin light 
chain kinase [21], with the existence of both mono- and 
di-phosphoproteins [23], a possible explanation for the 
two isolectric forms shown on two-dimensional gels in 
this study (Fig. 5). 
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Table II 
Amino acid analysis of the 20 kDa phosphoprotein 
Residue A B 
Asp/Ash 13.9 16.35 
Glu/GIn 26.9 13.25 
Set 4.96 4.28 
Gly 6.65 5.73 
His 1.46 1.34 
Arg 4.74 4.76 
Thr 3.69 6.69 
Aia 8.01 6.75 
Pro 4.39 3.13 
Tyr 1.49 2.25 
Val 3.2 2.26 
lie 1.7,.; 6.24 
Leu 4.55 6.18 
Phe 1.47 7.65 
Lys 8.21 8.19 
Met - 5.07 
Trp - 0 
Cys - 0.58 
95.3% 100..% 
Values are expressed as tool percent. Met, Trlo and Cys values were 
not determined. The amino acids are presented in the Table in their 
elution order drom the reverse-phase HPLC PTC column. Column A 
is the average of" three separate determinations of the amino acid 
analysis of the 20 kDa protein. Column B is the average tool% of two 
mammalian smooth muscle light chains in the EMBL database and 
of human nonsarcomeric 20kDa myosin regulatory light chain [24]. 
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